Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder

References

• Akboga MK, Canpolat U, Yuksel M, Yayla C, Yilmaz S, Turak O, Ozeke O, Topaloglu S, Aras D. 2016. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: a single center large-scale study. Platelets. 27(2):178–183.
   PubMed Web of Science ®Google Scholar
• Alsebaey A, Elhelbawy M, Waked I. 2018. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. Eur J Gastroenterol Hepatol. 30(2):207–211.
   PubMed Web of Science ®Google Scholar
• Anderson G, Maes M. 2015. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep. 17(2):8.
   PubMed Web of Science ®Google Scholar
• Aydin Sunbul E, Sunbul M, Yanartas O, Cengiz F, Bozbay M, Sari I, Gulec H. 2016. Increased neutrophil/lymphocyte ratio in patients with depression is correlated with the severity of depression and cardiovascular risk factors. Psychiatry Investig. 13(1):121.
   PubMed Web of Science ®Google Scholar
• Bahadir A, Baltaci D, Turker Y, Turker Y, Iliev D, Ozturk S, Deler MH, Sariguzel YC. 2015. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol. 15(10):816–822.
   PubMed Web of Science ®Google Scholar
• Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A. 2016. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 22(5):405–411.
   Google Scholar
• Balta S, Demirkol S, Aparcı M, Celik T, Ozturk C. 2014. The neutrophil lymphocyte ratio in coronary heart disease. Int J Cardiol. 176(1):267.
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, et al. 2011. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 35(3):804–817.
   PubMed Web of Science ®Google Scholar
• Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, McInnis MI, Grove TB, Brook RD, Zöllner SK, et al. 2014. Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disord. 16(3):277–288.
   PubMed Web of Science ®Google Scholar
• Budzianowski J, Pieszko K, Burchardt P, Rzeźniczak J, Hiczkiewicz J. 2017. The role of hematological indices in patients with acute coronarysyndrome. Dis Markers. 2017:1–9.
   Web of Science ®Google Scholar
• Buyukkaya E, Karakaş MF, Karakaş E, Akçay AB, Tanboga IH, Kurt M, Sen N. 2014. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 20(2):159–163.
   PubMed Web of Science ®Google Scholar
• Çakır U, Tuman TC, Yıldırım O. 2015. Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study. Psychiatr Danub. 27:180–184.
   PubMed Web of Science ®Google Scholar
• Calkin CV, Alda M. 2015. Insulin resistance in bipolar disorder: relevance to routine clinical care. Bipolar Disord. 17(6):683–688.
   PubMed Web of Science ®Google Scholar
• Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M. 2015. C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry. 76(02):142–150.
   PubMedGoogle Scholar
• Dargél AA, Roussel F, Volant S, Etain B, Grant R, Azorin J-M, M'Bailara K, Bellivier F, Bougerol T, Kahn J-P, the FACE-BD Collaborators, et al. 2018. Emotional hyper-reactivity and cardiometabolic risk in remitted bipolar patients: a machine learning approach. Acta Psychiatr Scand. 138(4):348–359.
   PubMed Web of Science ®Google Scholar
• Dargél AA, Volant S, Saha S, Etain B, Grant R, Azorin J-M, Gard S, Bellivier F, Bougerol T, Kahn J-P, FACE-BD orators, et al. 2019. Activation levels, cardiovascular risk, and functional impairment in remitted bipolar patients: clinical relevance of a dimensional approach. Psychother Psychosom. 88(1):45–47.
   PubMed Web of Science ®Google Scholar
• Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. 2015. Association of hematological indices with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 8:11420–11427.
   PubMed Web of Science ®Google Scholar
• Devaraj S, Valleggi S, Siegel D, Jialal I. 2010. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 12(2):110–118.
   PubMed Web of Science ®Google Scholar
• Faria SS, Fernandes PC, Silva MJB, Lima VC, Fontes W, Freitas-Junior R, Eterovic AK, Forget P. 2016. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 10:702.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Steiner J, Molendijk ML, Dodd S, Nardin P, Gonçalves C-A, Jacka F, Köhler CA, Karmakar C, Carvalho AF, et al. 2016. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet Psychiatry. 3(12):1147–1156.
   PubMed Web of Science ®Google Scholar
• Fries GR, Walss-Bass C, Bauer ME, Teixeira AL. 2019. Revisiting inflammation in bipolar disorder. Pharmacol Biochem Behav. 177:12–19.
   PubMed Web of Science ®Google Scholar
• Fuente-Tomas L. d l, Arranz B, Safont G, Sierra P, Sanchez-Autet M, Garcia-Blanco A, Garcia-Portilla MP. 2019. Classification of patients with bipolar disorder using k-means clustering. PLOS One. 14(1):e0210314.
   PubMed Web of Science ®Google Scholar
• Gama CS, Kunz M, Magalhães PVS, Kapczinski F. 2013. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Braz J Psychiatry. 35(1):70–74.
   PubMed Web of Science ®Google Scholar
• Gan Z, Wu X, Liao Y, Wu Y, He Z, Yang Z, Zhang Q. 2019. The association between low-grade inflammation and the clinical features of bipolar disorder in Han Chinese population. Psychoneuroendocrinology. 101:286–294.
   PubMed Web of Science ®Google Scholar
• Gao S-Q, Huang L-D, Dai R-J, Chen D-D, Hu W-J, Shan Y-F. 2015. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity. Int J Clin Exp Pathol. 8(11):14779–14785.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Saiz PA, Bascaran MT, Martíneza S, Benabarre A, Sierra P, Torres P, Montes JM, Bousoño M, Bobes J, et al. 2009. Cardiovascular risk in patients with bipolar disorder. J Affect Disord. 115(3):302–308.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, Livianos L, Torres P, Bobes J. 2008. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 106(1–2):197–201.
   PubMed Web of Science ®Google Scholar
• Garg R, Tripathy D, Dandona P. 2003. Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets. 4(6):487–492.
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Rapaport MH, Miller BJ. 2016. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 21(12):1696–1709.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol. 4:198–203.
   PubMedGoogle Scholar
• Guha P, Bhowmick K, Mazumder P, Ghosal M, Chakraborty I, Burman P. 2014. Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder. Ind J Clin Biochem. 29(1):51–56.
   PubMedGoogle Scholar
• Günaydın ZY, Çalgın MK, Bektaş O, Kaya A, Kaya Y, Bayramoğlu A. 2015. Correlation of platelet to lymphocyte ratio with presence and severity of metabolic syndrome. Mid Black Sea J of Health Sci. 1(3):18.
   Google Scholar
• Gutch M, Kumar S, Razi S, Gupta K, Gupta A. 2015. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 19(1):160–164.
   PubMedGoogle Scholar
• Kalelioglu T, Akkus M, Karamustafalioglu N, Genc A, Genc ES, Cansiz A, Emul M. 2015. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res. 228(3):925–927.
   PubMed Web of Science ®Google Scholar
• Kantola T, Klintrup K, Väyrynen JP, Vornanen J, Bloigu R, Karhu T, Herzig K-H, Näpänkangas J, Mäkelä J, Karttunen TJ, et al. 2012. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 107(10):1729–1736.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dias VV, Kauer-Sant'Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M. 2009. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 9(7):957–966.
   PubMed Web of Science ®Google Scholar
• Kawada T. 2013. Insulin-related biomarkers to predict the risk of metabolic syndrome. Int J Endocrinol Metab. 11(4):e10418.
   PubMedGoogle Scholar
• Kim J-K, Lee A-Y, Kang J-H, Yu B-Y, Kim S-J. 2018. Association of fasting glucose level with neutrophil-lymphocyte ratio compared to leukocyte count and serum C-reactive protein. Korean J Fam Med. 39(1):42–50.
   PubMed Web of Science ®Google Scholar
• Klöting N, Blüher M. 2014. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 15(4):277–287.
   PubMed Web of Science ®Google Scholar
• Landucci Bonifácio K, Sabbatini Barbosa D, Gastaldello Moreira E, de Farias CC, Higachi L, Camargo AEI, Favaro Soares J, Odebrecht Vargas H, Nunes SOV, Berk M, et al. 2017. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. J Affect Disord. 222:185–194.
   PubMed Web of Science ®Google Scholar
• Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, Kupfer DJ. 2012. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord. 141(1):1–10.
   PubMed Web of Science ®Google Scholar
• Lee S-Y, Chen S-L, Chang Y-H, Chen PS, Huang S-Y, Tzeng N-S, Wang Y-S, Wang L-J, Lee IH, Wang T-Y, et al. 2013. Inflammation's association with metabolic profiles before and after a twelve-week clinical trial in drug-naïve patients with bipolar II disorder. PLoS One. 8(6):e66847.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim NY, Na SH, Youn YH, Shin CS. 2018. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. 97(26):e11138.
   PubMed Web of Science ®Google Scholar
• Li H, Lu X, Xiong R, Wang S. 2017. High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients. Mediators Inflamm. 2017:9327136–9327138.
   PubMed Web of Science ®Google Scholar
• Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. 2015. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 15:9.
   PubMed Web of Science ®Google Scholar
• Marshe VS, Pira S, Mantere O, Bosche B, Looper KJ, Herrmann N, Müller DJ, Rej S. 2017. C-reactive protein and cardiovascular risk in bipolar disorder patients: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):442–451.
   PubMedGoogle Scholar
• Mayda H, Ahsen A, Bağcioğlu E, Öztürk A, Bahçeci B, Soyuçok E, Başpinar E, Ulu MS. 2016. Effect of increased neutrophil-to-lymphocyte ratio (NLR) and decreased mean platelet volume (MPV) values on inflammation in acute mania. Noro Psikiyatr Ars. 53(4):317–320.
   PubMedGoogle Scholar
• Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M. 2018. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuro Psychopharmacology Biol Psychiatry. 84:229–236.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Tringali AGM, Rossetti A, Botti RE, Clerici M. 2019. Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders. Gen Hosp Psychiatry. 58:7–12.
   PubMed Web of Science ®Google Scholar
• Melo MCA, Garcia RF, de Araújo CFC, Abreu RLC, d, Bruin PFC, d, Bruin VMS. 2019. Clinical significance of neutrophil-lymphocyte and platelet-lymphocyte ratios in bipolar patients: an 18-month prospective study. Psychiatry Res. 271:8–14.
   PubMed Web of Science ®Google Scholar
• Mert DG, Terzi H. 2016. Mean platelet volume in bipolar disorder: the search for an ideal biomarker. NDT. 12:2057–2062.
   Google Scholar
• Mertoglu C, Gunay M. 2017. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 11:S127–S131.
   PubMed Web of Science ®Google Scholar
• Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. 2013. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 74(1):15–25.
   PubMed Web of Science ®Google Scholar
• Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T, et al. 2013. Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 58(1):58–64.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Braüner JV, Kessing LV, Vinberg M. 2013. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 47(9):1119–1133.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Jacoby AS, Lenskjold T, Bruunsgaard H, Vinberg M, Kessing LV. 2018. Leukocytes in peripheral blood in patients with bipolar disorder – trait and state alterations and association with levels of cytokines and C-reactive protein. Psychiatry Res. 261:383–390.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Vinberg M, Vedel Kessing L. 2013. Cytokines in bipolar disorder: a systematic reviewand meta-analysis. J. Affect. Disord. 144(1-2):16–27.
   PubMed Web of Science ®Google Scholar
• Myint A-M, Kim Y-K. 2014. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 48:304–313.
   PubMed Web of Science ®Google Scholar
• Osimo EF, Cardinal RN, Jones PB, Khandaker GM. 2018. Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: an electronic health record-based study. Psychoneuroendocrinology. 91:226–234.
   PubMed Web of Science ®Google Scholar
• Özdin S, Sarisoy G, Böke Ö. 2017. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients – a retrospective file review. Nord J Psychiatry. 71(7):509–512.
   PubMed Web of Science ®Google Scholar
• Paulus JK, Dahabreh IJ, Balk EM, Avendano EE, Lau J, Ip S. 2014. Opportunities and challenges in using studies without a control group in comparative effectiveness reviews. Res Synth Methods. 5(2):152–161.
   PubMed Web of Science ®Google Scholar
• Sağlam Aykut D, Civil Arslan F, Özkorumak Karagüzel E, Aral G, Karakullukçu S. 2018. The relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and cognitive functions in bipolar disorder. Nord J Psychiatry. 72(2):119–123.
   PubMed Web of Science ®Google Scholar
• Sanchez-Autet M, Arranz B, Safont G, Sierra P, Garcia-Blanco A, de la Fuente L, Garriga M, García-Portilla MP. 2018. Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder. J Affect Disord. 229:95–104.
   PubMed Web of Science ®Google Scholar
• Shiny A, Bibin YS, Shanthirani CS, Regin BS, Anjana RM, Balasubramanyam M, Jebarani S, Mohan V. 2014. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. DiabetesTechnol. Ther. 16(8):524–530.
   Google Scholar
• Surendar J, Indulekha K, Mohan V, Pradeepa R. 2016. Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143). J. Diabetes Complications. 30(8):1525–1529.
   PubMed Web of Science ®Google Scholar
• Syauqy A, Hsu CY, Rau HH, Chao JC. 2018. Association of dietary patterns, anthropometric measurements, and metabolic parameters with C-reactive protein and neutrophil-to-lymphocyte ratio in middle-aged and older adults with metabolic syndrome in Taiwan: a cross-sectional study. Nutr J. 17(1):106.
   PubMedGoogle Scholar
• Tahto E, Jadric R, Pojskic L, Kicic E. 2017. Neutrophil-to-lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome. Med Arch. 71(5):312–315.
   PubMedGoogle Scholar
• Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM, Cicekler H, Anil M, Ozbek O, Selcuk NY, Yeksan M, et al. 2012. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail. 34(10):1229–1237.
   PubMed Web of Science ®Google Scholar
• Uemura H, Katsuura-Kamano S, Yamaguchi M, Bahari T, Ishizu M, Fujioka M, Arisawa K. 2017. Relationships of serum high-sensitivity C-reactive protein and body size with insulin resistance in a Japanese cohort. PLoS One. 12(6):e0178672.
   PubMed Web of Science ®Google Scholar
• van Rooy M-J, Pretorius E. 2015. Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke. Thromb Res. 135(3):434–442.
   PubMed Web of Science ®Google Scholar
• van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. 2008. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 10(2):342–348.
   PubMed Web of Science ®Google Scholar
• Vuksan-Cusa B, Sagud M, Jakovljević M. 2010. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia. Psychiatr Danub. 22(2):275–277.
   PubMed Web of Science ®Google Scholar
• Vuksan-Cusa B, Sagud M, Jakovljevic M, Peles AM, Jaksic N, Mihaljevic S, Zivkovic M, Mikulic SK, Jevtovic S. 2013. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. Nord J Psychiatry. 67(5):320–325.
   PubMed Web of Science ®Google Scholar
• Wysokiński A, Margulska A, Strzelecki D, Kłoszewska I. 2015. Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder. Nord J Psychiatry. 69(5):346–353.
   PubMed Web of Science ®Google Scholar
• Zahorec R. 2001. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 102:5–14.
   PubMedGoogle Scholar
• Zhou S, Cai B, Zhang Y, Wang L, Liu X, Xu G. 2017. The relationship between neutrophil-to-lymphocyte ratio and aortic arch calcification in ischemic stroke patients. J Stroke Cerebrovasc Dis. 26(6):1228–1232.
   PubMed Web of Science ®Google Scholar